Relypsa, Inc. et al v. Alkem Laboratories Ltd. et al
Case : 20-106
Judge: Judge Maryellen Noreika
Court: District of Delaware
Date: Jul. 20, 2021 – Claim construction – US 8,147,873, US 8,337,824, US 9,492,476 and US 9,925,212
Agreed-upon constructions:
1. “cation exchange, crosslinked . . . polymer or a salt thereof” means “crosslinked polymer or a salt thereof that is able to exchange cations” (’873 Patent, claim 1)
2. …
Arbor Pharmaceuticals, LLC et al v. Lupin Limited et al
Case : 20-922
Judge: Judge Maryellen Noreika
Court: District of Delaware
Date: Jul. 20, 2021 – Claim construction – US 9,066,936
Court’s construction of term: “pH control agent” shall be given its plain and ordinary meaning, which is “a substance or combination of substances that adjusts or maintains pH”
Plaintiffs proposed that the term should have its “plain and ordinary …
On July 16, 2021, in an unsealed opinion, Delaware Court granted Defendant’s motion on the pleading for non-infringement.
Plaintiff (Almirall) holds NDA for Aczone®(Dapsone) gel, 7.5%. Defendant (Torrent) filed ANDA with P-IV certification to market generic version of Aczone. Plaintiff sued Defendant for infringement of US 9,517,219 patent. The ‘219 patent describes and claims methods for treating acne vulgaris or rosacea by administering pharmaceutical compositions containing dapsone and certain inactive ingredients, specifically “a polymeric …
On July 20, 2021, Delhi High Court dismissed the appeals of Astrazeneca in an interim injunction case.
Plaintiff (Astrazeneca) owns IN 205147 (genus patent) & IN 235625 (species patent) covering dapagliflozin (DAPA) compound. IN 147 expired on Oct. 02, 2020 & IN 625 will expire on May 15, 2023. Plaintiff filed suit against many defendants (Intas / Alkem / Zydus / Eris / USV / Torrent / MSN / Micro labs / Ajanta) based …
In re: Entresto (Sacubitril/Valsartan) patent litigation
Case : 20-md-02930-LPS
Judge: Judge Leonard P. Stark
Court: District of Delaware
Date: Jul. 08, 2021 – Claim construction
In this multi-district litigation, Novartis sued multiple generic drug manufacturers (Alembic, Alkem, Aurobindo, Biocon, Crystal Pharma, Dr. Reddy’s Lab., Hetero, Laurus Labs, Lupin, Macleods, MSN Pharma, Mylan, Nanjing Noratech Pharma, Novugen Pharma, Teva , Torrent Pharma and Zydus). Novartis asserted that one or more of these Defendants …
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al
Case : 18-1606
Judge: Judge Richard G. Andrews
Court: District of Delaware
Date: Jun 23, 2021 – REPORT AND RECOMMENDATION
This is a Hatch-Waxman case. Plaintiff, Anacor Pharmaceuticals, Inc. markets Kerydin® (tavaborole), a topical solution indicated for the treatment of toenail fungus. Anacor is the assignee of U.S. Patent Nos. 9,549,938, 9,566,289, 9,566,290, and 9,572,823 (collectively, the “patents-in-suit”). The patents-in-suit claim methods and …
VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD
Case No. 19-13955
Judge: Chief Judge Freda L. Wolfson
Date: 06/28/2021
Court: District of New Jersey – OPINION – Claim construction
Plaintiffs Vifor (International) AG and American Regent, Inc. (collectively, “Plaintiffs”) brought the instant Hatch-Waxman patent infringement suit against Defendants Mylan Laboratories Ltd. and Sandoz Inc. (collectively “Defendants”). At issue in this claim construction dispute are five patents which share a …
MICROSPHERIX LLC v. MERCK SHARP & DOHME CORP. et al
Case No. 17-3984
Judge: Chief Mag. Judge Mark Falk
Date: 06/28/2021
Court: District of New Jersey – MEMORANDUM OPINION
This is a patent infringement case. Defendants (“Merck”) market and sell an implantable progestin contraceptive under the trade name Nexplanon®. Plaintiff, Microspherix, contends Nexplanon infringes three patents: US 9,636,401; US 9,636,402; and US 8,821,835. The initial complaint was filed on June …
